Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Jan 23;1(1):CD012103.
doi: 10.1002/14651858.CD012103.pub2.

Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews

Selma Mourad  1 , Julie Brown  2 , Cindy Farquhar  3
Affiliations
Meta-Analysis

Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews

Selma Mourad et al. Cochrane Database Syst Rev. .

Abstract

Background: Ovarian hyperstimulation syndrome (OHSS) in assisted reproductive technology (ART) cycles is a treatment-induced disease that has an estimated prevalence of 20% to 33% in its mild form and 3% to 8% in its moderate or severe form. These numbers might even be higher for high-risk women such as those with polycystic ovaries or a high oocyte yield from ovum pickup.

Objectives: The objective of this overview is to identify and summarise all evidence from Cochrane systematic reviews on interventions for prevention or treatment of moderate, severe and overall OHSS in couples with subfertility who are undergoing ART cycles.

Methods: Published Cochrane systematic reviews reporting on moderate, severe or overall OHSS as an outcome in ART cycles were eligible for inclusion in this overview. We also identified Cochrane submitted protocols and title registrations for future inclusion in the overview. The evidence is current to 12 December 2016. We identified reviews, protocols and titles by searching the Cochrane Gynaecology and Fertility Group Database of Systematic Reviews and Archie (the Cochrane information management system) in July 2016 on the effectiveness of interventions for outcomes of moderate, severe and overall OHSS. We undertook in duplicate selection of systematic reviews, data extraction and quality assessment. We used the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) tool to assess the quality of included reviews, and we used GRADE methods to assess the quality of the evidence for each outcome. We summarised the characteristics of included reviews in the text and in additional tables.

Main results: We included a total of 27 reviews in this overview. The reviews were generally of high quality according to AMSTAR ratings, and included studies provided evidence that ranged from very low to high in quality. Ten reviews had not been updated in the past three years. Seven reviews described interventions that provided a beneficial effect in reducing OHSS rates, and we categorised one additional review as 'promising'. Of the effective interventions, all except one had no detrimental effect on pregnancy outcomes. Evidence of at least moderate quality indicates that clinicians should consider the following interventions in ART cycles to reduce OHSS rates.• Metformin treatment before and during an ART cycle for women with PCOS (moderate-quality evidence).• Gonadotrophin-releasing hormone (GnRH) antagonist protocol in ART cycles (moderate-quality evidence).• GnRH agonist (GnRHa) trigger in donor oocyte or 'freeze-all' programmes (moderate-quality evidence). Evidence of low or very low quality suggests that clinicians should consider the following interventions in ART cycles to reduce OHSS rates.• Clomiphene citrate for controlled ovarian stimulation in ART cycles (low-quality evidence).• Cabergoline around the time of human chorionic gonadotrophin (hCG) administration or oocyte pickup in ART cycles (low-quality evidence).• Intravenous fluids (plasma expanders) around the time of hCG administration or oocyte pickup in ART cycles (very low-quality evidence).• Progesterone for luteal phase support in ART cycles (low-quality evidence).• Coasting (withholding gonadotrophins) - a promising intervention that needs to be researched further for reduction of OHSS.On the basis of this overview, we must conclude that evidence is currently insufficient to support the widespread practice of embryo cryopreservation.

Authors' conclusions: Currently, 27 reviews in the Cochrane Library were conducted to report on or to try to report on OHSS in ART cycles. We identified four review protocols but no new registered titles that can potentially be included in this overview in the future. This overview provides the most up-to-date evidence on prevention of OHSS in ART cycles from all currently published Cochrane reviews on ART. Clinicians can use the evidence summarised in this overview to choose the best treatment regimen for individual patients - a regimen that not only reduces the chance of developing OHSS but does not compromise other outcomes such as pregnancy or live birth rate. Review results, however, are limited by the lack of recent primary studies or updated reviews. Furthermore, this overview can be used by policymakers in developing local and regional protocols or guidelines and can reveal knowledge gaps for future research.

PubMed Disclaimer

Conflict of interest statement

All three overview authors (SM, JB,CF) were co‐review authors on several of the included reviews. CF is a director/shareholder of a small day stay surgical unit and gynaecology clinic and undertakes private practice within these facilities. She has received travel/accommodation/meeting expenses from ESHRE or ASRM for attendance at scientific meetings. She does not receive any industry or commercial payments for research or travel. SM and JB report no conflicts of interest regarding industry.

Figures

1
1
Flow diagram of included reviews.
2
2
Extent of effect of interventions on OHSS rate and live birth rate (when reported) or clinical pregnancy: OR and 95% CI.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD012103

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to included reviews

Al‐Inany 2016
    1. Al‐Inany HG, Youssef MAFM, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD001750.pub4] - DOI - PMC - PubMed
Albuquerque 2013
    1. Albuquerque LET, Tso LO, Saconato H, Albuquerque MCRM, Macedo CR. Depot versus daily administration of gonadotrophin‐releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD002808.pub3] - DOI - PMC - PubMed
Allersma 2013
    1. Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD010550.pub2] - DOI - PMC - PubMed
Boomsma 2012
    1. Boomsma CM, Keay SD, Macklon NS. Peri‐implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD005996.pub3] - DOI - PubMed
Cheong 2013
    1. Cheong YC, Dix S, Hung Yu Ng E, Ledger WL, Farquhar C. Acupuncture and assisted reproductive technology. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD006920.pub3] - DOI - PMC - PubMed
D'Angelo 2007
    1. D'Angelo A, Amso NN. Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD002806.pub2] - DOI - PMC - PubMed
D'Angelo 2011
    1. D'Angelo A, Brown J, Amso NN. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD002811.pub3] - DOI - PubMed
Duffy 2010
    1. Duffy JMN, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD000099.pub3] - DOI - PMC - PubMed
Gibreel 2012
    1. Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD008528.pub2] - DOI - PubMed
Kwan 2014
    1. Kwan I, Bhattacharya S, Kang A, Woolner A. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD005289.pub3] - DOI - PMC - PubMed
Martins 2013
    1. Martins WP, Vieira ADD, Figueiredo JBP, Nastri CO. FSH replaced by low‐dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD010042.pub2] - DOI - PMC - PubMed
Mochtar 2007
    1. Mochtar MH, Veen F, Ziech M, Wely M, Musters A. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005070.pub2] - DOI - PubMed
Pandian 2015
    1. Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD003357.pub3] - DOI - PubMed
Pouwer 2015
    1. Pouwer AW, Farquhar C, Kremer JAM. Long‐acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD009577.pub3] - DOI - PMC - PubMed
Showell 2013
    1. Showell MG, Brown J, Clarke J, Hart RJ. Antioxidants for female subfertility. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD007807.pub2] - DOI - PubMed
Siristatidis 2009
    1. Siristatidis CS, Maheshwari A, Bhattacharya S. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006606.pub2] - DOI - PMC - PubMed
Siristatidis 2015
    1. Siristatidis Charalampos S, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2015, issue 11. [DOI: 10.1002/14651858.CD006919.pub4; CD006919] - DOI - PMC - PubMed
Siristatidis 2016
    1. Siristatidis CS, Basios G, Pergialiotis V, Vogiatzi P. Aspirin for in vitro fertilisation. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD004832.pub4] - DOI - PMC - PubMed
Smulders 2010
    1. Smulders B, Oirschot SM, Farquhar C, Rombauts L, Kremer JAM. Oral contraceptive pill, progestogen or estrogen pre‐treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006109.pub2] - DOI - PubMed
Tang 2016
    1. Tang H, Mourad S, Zhai SD, Hart RJ. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD008605.pub3] - DOI - PMC - PubMed
Tso 2014
    1. Tso LO, Costello MF, Albuquerque LET, Andriolo RB, Macedo CR. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD006105.pub3] - DOI - PMC - PubMed
van der Linden 2015
    1. Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD009154.pub3] - DOI - PMC - PubMed
van Wely 2011
    1. Wely M, Kwan I, Burt AL, Thomas J, Vail A, Veen F, Al‐Inany HG. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD005354.pub2] - DOI - PMC - PubMed
Yossry 2006
    1. Yossry M, Aboulghar M, D'Angelo A, Gillett W. In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004144.pub2] - DOI - PMC - PubMed
Youssef 2014
    1. Youssef MAFM, Veen F, Al‐Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin‐releasing hormone agonist versus HCG for oocyte triggering in antagonist‐assisted reproductive technology. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD008046.pub4] - DOI - PMC - PubMed
Youssef 2016
    1. Youssef MA, Abou‐Setta AM, Lam WS. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD003719.pub4] - DOI - PMC - PubMed
Youssef 2016b
    1. Youssef MA, Mourad S. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2016, Issue 8. [DOI: 10.1002/14651858.CD001302.pub3] - DOI - PMC - PubMed

References to excluded reviews

Abou‐Setta 2014
    1. Abou‐Setta AM, Peters LR, D'Angelo A, Sallam HN, Hart RJ, Al‐Inany HG. Post‐embryo transfer interventions for assisted reproduction technology cycles. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD006567.pub3] - DOI - PMC - PubMed
Akhtar 2013
    1. Akhtar M, Sur S, Raine‐Fenning N, Jayaprakasan K, Thornton JG, Quenby S. Heparin for assisted reproduction. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD009452.pub2] - DOI - PMC - PubMed
Anderson 2010
    1. Anderson K, Norman RJ, Middleton P. Preconception lifestyle advice for people with subfertility. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD008189.pub2] - DOI - PubMed
Armstrong 2015
    1. Armstrong S, Arroll N, Cree LM, Jordan V, Farquhar C. Time‐lapse systems for embryo incubation and assessment in assisted reproduction. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD011320.pub2] - DOI - PubMed
Benschop 2010
    1. Benschop L, Farquhar C, Poel N, Heineman MJ. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD008571.pub2] - DOI - PMC - PubMed
Bontekoe 2012
    1. Bontekoe S, Mantikou E, Wely M, Seshadri S, Repping S, Mastenbroek S. Low oxygen concentrations for embryo culture in assisted reproductive technologies. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD008950.pub2] - DOI - PMC - PubMed
Bontekoe 2014
    1. Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD007421.pub3] - DOI - PMC - PubMed
Brown 2010
    1. Brown J, Buckingham K, Abou‐Setta AM, Buckett W. Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006107.pub3] - DOI - PubMed
Carney 2012
    1. Carney SK, Das S, Blake D, Farquhar C, Seif MM, Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI)). Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD001894.pub5] - DOI - PMC - PubMed
Derks 2009
    1. Derks RS, Farquhar C, Mol BWJ, Buckingham K, Heineman MJ. Techniques for preparation prior to embryo transfer. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007682.pub2] - DOI - PubMed
Ghobara 2008
    1. Ghobara T, Vanderkerchove P. Cycle regimens for frozen‐thawed embryo transfer. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003414.pub2] - DOI - PubMed
Glujovsky 2010
    1. Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006359.pub2] - DOI - PubMed
Glujovsky 2012
    1. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD002118.pub4] - DOI - PubMed
Glujovsky 2014
    1. Glujovsky D, Riestra B, Sueldo C, Fiszbajn G, Repping S, Nodar F, et al. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD010047.pub2] - DOI - PMC - PubMed
Gunby 2004
    1. Gunby JL, Daya S, Olive D, Brown J. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD004378.pub2] - DOI - PubMed
Gutarra‐Vilchez 2014
    1. Gutarra‐Vilchez RB, Urrútia G, Glujovsky D, Coscia A, Bonfill Cosp X. Vasodilators for women undergoing fertility treatment. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD010001.pub2] - DOI - PubMed
Huang 2013
    1. Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Brief co‐incubation of sperm and oocytes for in vitro fertilization techniques. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD009391.pub2] - DOI - PMC - PubMed
Johnson 2010
    1. Johnson N, Voorst S, Sowter MC, Strandell A, Mol BWJ. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD002125.pub3] - DOI - PMC - PubMed
Kroon 2012
    1. Kroon B, Hart RJ, Wong BMS, Ford E, Yazdani A. Antibiotics prior to embryo transfer in ART. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD008995.pub2] - DOI - PubMed
Kwan 2013
    1. Kwan I, Bhattacharya S, Knox F, McNeil A. Pain relief for women undergoing oocyte retrieval for assisted reproduction. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD004829.pub3] - DOI - PubMed
Maheshwari 2011
    1. Maheshwari A, Gibreel A, Siristatidis CS, Bhattacharya S. Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD006919.pub3] - DOI - PubMed
McDonnell 2014
    1. McDonnell R, Marjoribanks J, Hart RJ. Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD005999.pub2] - DOI - PMC - PubMed
McDowell 2014
    1. McDowell S, Kroon B, Ford E, Hook Y, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD010461.pub2] - DOI - PubMed
Nastri 2015
    1. Nastri CO, Lensen SF, Gibreel A, Raine‐Fenning N, Ferriani RA, Bhattacharya S, et al. Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews 2015, Issue 3. [DOI: 10.1002/14651858.CD009517] - DOI - PubMed
Pandian 2010
    1. Pandian Z, McTavish AR, Aucott L, Hamilton MPR, Bhattacharya S. Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in‐vitro fertilisation (IVF). Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD004379.pub3] - DOI - PubMed
Pandian 2013
    1. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra‐cytoplasmic sperm injection. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD003416.pub4] - DOI - PMC - PubMed
Proctor 2008
    1. Proctor M, Johnson N, Peperstraten AM, Phillipson G. Techniques for surgical retrieval of sperm prior to intra‐cytoplasmic sperm injection (ICSI) for azoospermia. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002807.pub3] - DOI - PMC - PubMed
Sallam 2006
    1. Sallam HN, Garcia‐Velasco JA, Dias S, Arici A, Abou‐Setta AM. Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD004635.pub2] - DOI - PMC - PubMed
Showell 2014
    1. Showell MG, Mackenzie‐Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD007411.pub3] - DOI - PubMed
Teixeira 2013
    1. Teixeira DM, Barbosa MAP, Ferriani RA, Navarro PA, Raine‐Fenning N, Nastri CO, et al. Regular (ICSI) versus ultra‐high magnification (IMSI) sperm selection for assisted reproduction. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010167.pub2] - DOI - PubMed
Twisk 2006
    1. Twisk M, Mastenbroek S, Wely M, Heineman MJ, Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005291.pub2] - DOI - PubMed
Van Rumste 2003
    1. Rumste MME, Evers JLH, Farquhar C. Intra‐cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in couples with non‐male subfertility. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD001301] - DOI - PubMed
Wongtra‐ngan 2010
    1. Wongtra‐ngan S, Vutyavanich T, Brown J. Follicular flushing during oocyte retrieval in assisted reproductive techniques. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD004634.pub2] - DOI - PubMed

Additional references

Aboulghar 2003
    1. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Human Reproduction Update 2003;9(3):275‐89. - PubMed
Abramov 1999
    1. Abramov Y, Elchalal U, Schenker JG. Severe OHSS: an 'epidemic' of severe OHSS: a price we have to pay?. Human Reproduction 1999;14(9):2181‐3. - PubMed
Agrawal 1999
    1. Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N, et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertility and Sterility 1999;71(2):287–93. - PubMed
ASRM 2016
    1. Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertility and Sterility 2016;106(7):1634‐47. - PubMed
Baumgarten 2013
    1. Baumgarten M, Polanski L, Campbell B, Raine‐Fenning N. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta‐analysis. Human Fertility (Cambridge) 2013;16(3):168‐74. - PubMed
Becker 2011
    1. Becker LA, Oxman AD. Chapter 22: Overviews of reviews. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org.
Braat 2006
    1. Braat D, Bernardus R, Gerris J. Anonymous reports of lethal cases of ovarian hyperstimulation syndrome. In: Gerris J, Olivennes F, Delvigne A editor(s). Ovarian Hyperstimulation Syndrome. London: Informa UK Limited, 2006:59‐66.
De Geyter 2015
    1. Geyter C, Fehr P, Moffat R, Gruber IM, Wolff M. Twenty years' experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice. Swiss Medical Weekly 2015;145:w14087. [DOI: 10.4414/smw.2015.14087] - DOI - PubMed
Delbaere 2004
    1. Delbaere A, Smits G, Olatunbosun O, Pierson R, Vassart G, Costagliola S. New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?. Human Reproduction 2004;19(3):486‐9. - PMC - PubMed
Delbaere 2005
    1. Delbaere A, Smits G, Leener A, Costagliola S, Vassart G. Understanding ovarian hyperstimulation syndrome. Endocrine 2005;26(3):285‐90. - PubMed
Delvigne 2002
    1. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update 2002;8(6):559‐77. - PubMed
Farquhar 2015
    1. Farquhar C, Rishworth JR, Brown J, Nelen WLDM, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD010537.pub4] - DOI - PubMed
Golan 1989
    1. Golan A, Ron‐El R, Herman A, Soffer Y, Wainraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstetrical and Gynecological Survey 1989;44(6):430‐40. - PubMed
GRADEpro GDT
    1. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime Inc.). www.gradepro.org.
Guo 2016
    1. Guo JL, Zhang DD, Zhao Y, Zhang D, Zhang XM, Zhou CQ, et al. Pharmacologic interventions in preventing ovarian hyperstimulation syndrome: a systematic review and network meta‐analysis. Scientific Reports 2016;11(6):19093.doi:10.1038/srep19093. - PMC - PubMed
Guyatt 2008
    1. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schünemann HJ, GRADE Working Group. Rating quality of evidence and strength of recommendations: what is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995‐8. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org.
Kalampokas 2013
    1. Kalampokas T, Creatsas G, Kalampokas E. Cabergoline as treatment of ovarian hyperstimulation syndrome: a review. Gynecological Endocrinology 2013;29(2):98‐100. - PubMed
Kasum 2015
    1. Kasum M, Vrcic H, Stanic P, Jezek D, Oreskovic S, Beketic‐Oreskovic L, et al. Dopamine agonists in prevention of ovarian hyperstimulation syndrome. Gynecological Endocrinology 2014;30(12):845‐9. - PubMed
Kol 2011
    1. Kol S. Ovarian hyperstimulation syndrome prevention. Global Library of Women's Medicine, 2011. [DOI: 10.3843/GLOWM.10466; ISSN:1756‐2228] - DOI
Kupka 2014
    1. Kupka MS, Ferraretti AP, Mouzon J, Erb K, D'Hooghe T, Castilla JA, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE. Human Reproduction 2014;29(10):2099‐113. - PubMed
Kwik 2016
    1. Kwik M, Maxwell E. Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome. Current Opinion in Obstetrics and Gynecology 2016;28(4):236‐41. - PubMed
Leitao 2014
    1. Leitao VM, Moroni RM, Seko LM, Nastri Co, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta‐analysis of randomized controlled trials. Fertility and Sterility 2014;101(3):664‐75. - PubMed
Mathur 2000
    1. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertility and Sterility 2000;73(5):901‐7. - PubMed
Navot 1992
    1. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertility and Sterility 1992;58(2):249‐61. - PubMed
Rabau 1967
    1. Rabau E, Serr DM, David A, Maschiac S, Lunenfield B. Human menopausal gonadotropins for anovulation and sterility. American Journal of Obstetrics and Gynaecology 1967;98:92‐8. - PubMed
Rizk 1999
    1. Rizk B, Aboulghar MA. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In: Brinsden P editor(s). In‐Vitro Fertilization and Assisted Reproduction. New York, London: The Parthenon Publishing Group, 1999:131‐55.
Schenker 1978
    1. Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertility and Sterility 1978;30(3):255‐68. - PubMed
Schenker 1994
    1. Schenker JG, Ezra Y. Complications of assisted reproductive techniques. Fertility and Sterility 1994;61(3):411‐22. - PubMed
Schünemann 2013
    1. Schünemann H, Brozek J, Guyatt G, Oxman A (editors). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated March 2013. http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook... (accessed 15 November 2015).
Shea 2007
    1. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;7:10. - PMC - PubMed
Stewart 1997
    1. Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Human Reproduction 1997;12(10):2167‐73. - PubMed

Publication types

MeSH terms

LinkOut - more resources